Literature DB >> 28450943

Clinicopathological significance of ROCK1 and PIK3CA expression in nasopharyngeal carcinoma.

Xuanyi Wang1,2, Yuxiang Huang3, Renhua Guo4, Yongbiao Liu5, Yayun Qian2, Dan Liu6, Xiaojun Dai2, Zheng Wei2, Feng Jin2, Yanqing Liu2.   

Abstract

The aim of the present study was to determine the expression of rho-associated coiled-coil-containing protein kinase 1 (ROCK1) and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA) in nasopharyngeal carcinoma (NPC), and to assess the association between the expression of these proteins and the clinicopathological features of NPC. ROCK1 and PIK3CA expressions were assessed in a tissue microarray of sections prepared from the tumors of 81 patients with NPC using immunohistochemistry. Western blot analysis was used to detect ROCK1 and PIK3CA expression in NP69 and 5-8F cells. χ2 analysis revealed that upregulation of ROCK1 was significantly associated with advanced N stage (P=0.032) cancer and increased PIK3CA expression was significantly associated with advanced N stage (P=0.027) and TNM stage (P=0.019) cancer. Furthermore, ROCK1 expression was significantly positively correlated with PIK3CA expression (P=0.01). Western blot analysis demonstrated that levels of ROCK1 (P<0.001) and PIK3CA (P=0.015) were significantly higher in 5-8F cells compared with NP69 cells. The results of the present study indicate that high levels of ROCK1 and PIK3CA expression may be associated with advanced stages in NPC.

Entities:  

Keywords:  immunohistochemistry; nasopharyngeal carcinoma; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α; rho-associated coiled-coil-containing protein kinase 1; tissue microarray

Year:  2017        PMID: 28450943      PMCID: PMC5403356          DOI: 10.3892/etm.2017.4076

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  26 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.

Authors:  Ya-Sian Chang; Hui-Ting Hsu; Ying-Chin Ko; Kun-Tu Yeh; Shun-Jen Chang; Chien-Yu Lin; Jan-Gowth Chang
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2014-04-05

Review 3.  Gene of the month: PIK3CA.

Authors:  K Lai; M C Killingsworth; C S Lee
Journal:  J Clin Pathol       Date:  2015-02-16       Impact factor: 3.411

4.  To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area.

Authors:  Y Jin; X Y Cai; Y C Cai; Y Cao; Q Xia; Y T Tan; W Q Jiang; Y X Shi
Journal:  Eur J Cancer       Date:  2011-10-24       Impact factor: 9.162

5.  Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma.

Authors:  Meixiang Li; Cui Li; Danjuan Li; Yuanjie Xie; Jinfeng Shi; Guoqing Li; Yongjun Guan; Maoyu Li; Pengfei Zhang; Fang Peng; Zhiqiang Xiao; Zhuchu Chen
Journal:  Clin Exp Metastasis       Date:  2012-06-17       Impact factor: 5.150

Review 6.  The battle against nasopharyngeal cancer.

Authors:  Anne W M Lee; W T Ng; Y H Chan; Henry Sze; Connie Chan; T H Lam
Journal:  Radiother Oncol       Date:  2012-08-30       Impact factor: 6.280

7.  Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma.

Authors:  Junbo Zhang; Xue He; Yueying Ma; Yanli Liu; Huaiyin Shi; Weiwei Guo; Liangfa Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

8.  DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.

Authors:  V Tripathi; N C Popescu; D B Zimonjic
Journal:  Oncogene       Date:  2013-02-04       Impact factor: 9.867

9.  PIK3CA mutation associates with improved outcome in breast cancer.

Authors:  Kevin Kalinsky; Lindsay M Jacks; Adriana Heguy; Sujata Patil; Marija Drobnjak; Umeshkumar K Bhanot; Cyrus V Hedvat; Tiffany A Traina; David Solit; William Gerald; Mary Ellen Moynahan
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

10.  Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.

Authors:  Ludovic Barault; Nicolas Veyrie; Valerie Jooste; Delphine Lecorre; Caroline Chapusot; Jean-Marc Ferraz; Astrid Lièvre; Marion Cortet; Anne-Marie Bouvier; Patrick Rat; Patrick Roignot; Jean Faivre; Pierre Laurent-Puig; Francoise Piard
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

View more
  4 in total

1.  PVT1 Mediates Cell Proliferation, Apoptosis and Radioresistance in Nasopharyngeal Carcinoma Through Regulating miR-515-5p/PIK3CA Axis.

Authors:  Yanyan Han; Fang Li; Jun Xie; Yi Wang; Hua Zhang
Journal:  Cancer Manag Res       Date:  2020-10-13       Impact factor: 3.989

2.  Cytoplasmic Clusterin Suppresses Lung Cancer Metastasis by Inhibiting the ROCK1-ERK Axis.

Authors:  Shaobo Huang; Xu Li; Weiqi Gu; Xiaoyi Li; Jingjing Zhao; Jueheng Wu; Junchao Cai; Xianming Feng; Tianyu Tao
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

3.  Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.

Authors:  Charissa N Kahue; Rachel J Jerrell; Aron Parekh
Journal:  Cancer Rep (Hoboken)       Date:  2018-07-27

4.  Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan.

Authors:  Sheng-Dean Luo; Wei-Chih Chen; Ching-Nung Wu; Yao-Hsu Yang; Shau-Hsuan Li; Fu-Min Fang; Tai-Lin Huang; Yu-Ming Wang; Tai-Jan Chiu; Shao-Chun Wu
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.